IDEAYA Biosciences Inc header image

IDEAYA Biosciences Inc

IDYA

Equity

ISIN null / Valor 47686107

NASDAQ (2026-04-07)
USD 30.91-4.42%

IDEAYA Biosciences Inc
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

IDEAYA Biosciences Inc. is a clinical-stage precision medicine oncology company based in South San Francisco, California. The company focuses on the discovery and development of targeted therapeutics for cancer patients, utilizing molecular diagnostics to select patient populations. IDEAYA's primary area of expertise is in synthetic lethality, a novel class of precision medicine targets. The company integrates target and biomarker discovery with the development of small molecule and protein degrader therapeutics, spanning from early discovery stages through clinical development. IDEAYA aims to address unmet needs in cancer treatment by advancing therapeutics that have the potential to be first-in-class or best-in-class.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

104%1Y
118%3Y
48.0%5Y

Performance

52.7%1Y
52.2%3Y
60.1%5Y

Volatility

Market cap

2714 M

Market cap (USD)

Daily traded volume (Shares)

1,441,396

Daily traded volume (Shares)

1 day high/low

25.07 / 24.31

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Wesley Jefferson Yap
United Kingdom, 04 Nov 2025
star star star star star
What an increase, even though it is temporary

EQUITIES OF THE SAME SECTOR

Nuvalent Inc
Nuvalent Inc Nuvalent Inc Valor: 112589757
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.41%USD 102.25
Keros Therapeutics Inc
Keros Therapeutics Inc Keros Therapeutics Inc Valor: 53581630
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.12%USD 12.24
Geron Corporation (Delaware)
Geron Corporation (Delaware) Geron Corporation (Delaware) Valor: 145973
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.57%USD 1.74
Adobe Inc
Adobe Inc Adobe Inc Valor: 903472
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.72%USD 240.14
Automatic Data Processing Inc
Automatic Data Processing Inc Automatic Data Processing Inc Valor: 910042
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%USD 203.61
Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Valor: 965755
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%USD 760.27
WW Grainger Inc
WW Grainger Inc WW Grainger Inc Valor: 935590
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.81%USD 1,108.15
Gartner Inc
Gartner Inc Gartner Inc Valor: 117812
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.58%USD 148.67
Hewlett Packard Enterprise Co
Hewlett Packard Enterprise Co Hewlett Packard Enterprise Co Valor: 29968909
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.20%USD 24.63
Jabil Inc
Jabil Inc Jabil Inc Valor: 71588
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.01%USD 272.85